{"preliminary_commentary":{"by_channel":{"x_thread":4},"note":"Preliminary. Indexed podcasts, YouTube videos and X posts that name this trial so far. This is where a report starts, not where it ends: the build searches for more, so finished reports usually cover more than this."},"free_build":{"available":false},"commentary_summary":null,"drugs_tested":[],"indication":"early-stage non-small cell lung cancer","name":"MISSILE-NSCLC","nct_id":"NCT02136355","offer":{"currency":"USD","how":"Order at https://www.erudio.com/contact?report=missile-nsclc-nct02136355. The price is an estimate of verified statements from the commentary indexed so far. Final coverage is set when the report is built. You never pay more than quoted: if the report is delivered at a smaller size, you pay that size's price, and anything paid above it is refunded. We build the report within 24 hours of confirming the order and deliver it when it passes our checks; if it cannot be built to our standard, nothing is charged.","price_rule":"Never more than quoted: the buyer pays the smaller of price_usd and the price the delivered edition is sold at.","price_usd":750,"size":"focused","size_rule":"Focused: 1–150 verified statements, estimated at 14 per indexed commentary source"},"registry":{"acronym":null,"arms":[{"description":"Stereotactic body radiation therapy followed by surgical resection","label":"Stereotactic Body Radiation Therapy plus Surgery","type":"EXPERIMENTAL"}],"collaborators":[],"completion_date":{"date":"2022-11-25","type":"ACTUAL"},"conditions":["Non Small Cell Lung Cancer"],"enrollment":{"count":40,"type":"ACTUAL"},"has_results":false,"interventions":[{"name":"Stereotactic Body Radiation Therapy plus Surgery","otherNames":[],"type":"RADIATION"}],"last_update":"2023-03-08","lead_sponsor":"London Health Sciences Centre Research Institute OR Lawson Research Institute of St. Joseph's","official_title":"A Phase II Trial Measuring the Integration of Stereotactic Radiotherapy Plus Surgery in Early Non-Small Cell Lung Cancer","overall_status":"COMPLETED","phases":["NA"],"primary_completion_date":{"date":"2022-11-25","type":"ACTUAL"},"primary_outcomes":[{"measure":"Tumor response","timeFrame":"2.5 years"}],"references":[{"citation":"Yang DM, Palma DA, Kwan K, Louie AV, Malthaner R, Fortin D, Rodrigues GB, Yaremko BP, Laba J, Gaede S, Warner A, Inculet R, Lee TY. Predicting pathological complete response (pCR) after stereotactic ablative radiation therapy (SABR) of lung cancer using quantitative dynamic [18F]FDG PET and CT perfusion: a prospective exploratory clinical study. Radiat Oncol. 2021 Jan 13;16(1):11. doi: 10.1186/s13014-021-01747-z.","pmid":"33441162","type":"DERIVED"},{"citation":"Palma DA, Nguyen TK, Louie AV, Malthaner R, Fortin D, Rodrigues GB, Yaremko B, Laba J, Kwan K, Gaede S, Lee T, Ward A, Warner A, Inculet R. Measuring the Integration of Stereotactic Ablative Radiotherapy Plus Surgery for Early-Stage Non-Small Cell Lung Cancer: A Phase 2 Clinical Trial. JAMA Oncol. 2019 May 1;5(5):681-688. doi: 10.1001/jamaoncol.2018.6993.","pmid":"30789648","type":"DERIVED"},{"citation":"Palma DA, Nguyen TK, Kwan K, Gaede S, Landis M, Malthaner R, Fortin D, Louie AV, Frechette E, Rodrigues GB, Yaremko B, Yu E, Dar AR, Lee TY, Gratton A, Warner A, Ward A, Inculet R. Short report: interim safety results for a phase II trial measuring the integration of stereotactic ablative radiotherapy (SABR) plus surgery for early stage non-small cell lung cancer (MISSILE-NSCLC). Radiat Oncol. 2017 Jan 27;12(1):30. doi: 10.1186/s13014-017-0770-7.","pmid":"28129789","type":"DERIVED"}],"start_date":{"date":"2014-09"},"study_type":"INTERVENTIONAL","title":"A Phase II Trial Measuring the Integration of Stereotactic Radiotherapy Plus Surgery in Early Non-Small Cell Lung Cancer","url":"https://clinicaltrials.gov/study/NCT02136355"},"report":null,"schema_id":"erudio.trial_listing","schema_version":"3.2","state":"listed","state_text":"No report yet. It can be ordered.","url":"https://www.erudio.com/trials/missile-nsclc-nct02136355"}